Literature DB >> 4348975

Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells.

S G Rabinowitz, W H Adler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4348975

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  14 in total

1.  Ultrastructural and serological studies on the resistance of activated B cells to the cytotoxic effects of anti-immunoglobulin serum. Patch and cap formation of surface immunoglobulin on mitotic B lymphocytes.

Authors:  R S Kerbel; M S Birbeck; D Robertson; P Cartwright
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Extension of the mean time to death of mice with a lethal infection of Venezuelan equine encephalomyelitis virus by antithymocyte serum treatment.

Authors:  D R Woodman; A T McManus; G A Eddy
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

3.  Delayed-type hypersensitivity against Semliki Forest virus in mice.

Authors:  C A Kraaijeveld; M Harmsen; B Khader Boutahar-Trouw
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  Melatonin treatment enhances the efficiency of mice immunization with Venezuelan equine encephalomyelitis virus TC-83.

Authors:  B Negrette; E Bonilla; N Valero; H Pons; J Garcia Tamayo; L Chacín-Bonilla; S Medina-Leendertz; F Añez
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

5.  Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice.

Authors:  J Stanley; S J Cooper; D E Griffin
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

6.  Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Anaís Nery; Ernesto Bonilla; Luz Marina Espina; Leonor Chacin-Bonilla; Florencio Añez; Mery Maldonado; Eddy Meleán
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

7.  Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.

Authors:  M S Ascher; P B Jahrling; D G Harrington; R A Kishimoto; V G McGann
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

8.  Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.

Authors:  C A Kraaijeveld; B J Benaissa-Trouw; M Harmsen; H Snippe
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.

Authors:  Pankaj Pal; Julie M Fox; David W Hawman; Yan-Jang S Huang; Ilhem Messaoudi; Craig Kreklywich; Michael Denton; Alfred W Legasse; Patricia P Smith; Syd Johnson; Michael K Axthelm; Dana L Vanlandingham; Daniel N Streblow; Stephen Higgs; Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

10.  Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.

Authors:  W A Boere; T Harmsen; J Vinjé; B J Benaissa-Trouw; C A Kraaijeveld; H Snippe
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.